Basler Kantonalbank Share Price

Certificat

ATLBKB

CH1225279855

Real-time Bid/Ask 06:07:19 06/06/2024 pm IST
101.42 CHF / 102.23 CHF +0.53% Intraday chart for Basler Kantonalbank
3 months+1.17%
6 months+12.62%
Date Price Change
05/24/05 101.3 +0.12%
04/24/04 101.2 +0.18%

Delayed Quote Swiss Exchange

Last update June 05, 2024 at 08:50 pm IST

More quotes

Static data

Product typeCertificati Azionari e Obbl.ri
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Basler Kantonalbank
ATLBKB
ISINCH1225279855
Date issued 07/12/2022
Strike 301.2 CHF
Maturity 09/12/2024 (186 Days)
Parity 0.3 : 1
Emission price 100 CHF
Emission volume N/A
Settlement entrambi
Currency CHF

Technical Indicators

Highest since issue 103.4 CHF
Lowest since issue 82.72 CHF
Spread 8.1 CHF
Spread %0.79%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
236.1 CHF
Average target price
277.5 CHF
Spread / Average Target
+17.55%
Consensus
  1. Stock Market
  2. Certificates
  3. ATLBKB Certificat